Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model

Angella M Anthony Jalin, Chae Kwan Lee, Chae Yeon Lee, A. Reum Kang, Chung Mu Park, Jae Ho Cha, Jeong Hwan Kim, Soo Woong Lee, Young Sun Song, Jong-Tae Lee, Sung Goo Kang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cheonggukjang is a soybean paste made by fermenting whole cooked soybeans with Bacillus subtilis. Cheonggukjang contains a fibrinolytic enzyme that could provide clinical applications for removing blood clots. In the present study, the term "cheonggukjang kinase" (CGK) was used to refer to this fibrinolytic enzyme. The thrombolytic effects of CGK were analyzed in a rat model of cerebral embolic stroke produced by middle cerebral artery occlusion (MCAO). Results from fibrin and platelet-rich clot lysis assays demonstrated that thrombolytic activity was greatest in CGKs, which were cultured for 40 hours. In addition, T50, the time needed to decompose 50% of the clot, did not change with plasminogen treatment, indicating that CGK was not a plasminogen activator, but was rather presumed to act as a plasmin-like protein. An intravenous infusion of CGK (1 U plasmin-like activity/100 μg CGK/kg) at 1 hour after MCAO resulted in removal of clots in a rat model of cerebral embolic stroke. CGK-treated groups exhibited a significant dose-dependent reduction in infarct volume. CGK treatment also improved functional recovery, as assessed by neurological deficit scores. Decreased infarct volume and improved functional recovery following CGK treatment was greater compared with recombinant tissue plasminogen activator (10 mg/kg). These results suggested that CGK effectively reduced infarct volume and improved functional recovery following ischemic brain injury. CGK exhibits a number of potential clinical applications in the treatment of cerebral embolic stroke.

Original languageEnglish
Pages (from-to)1875-1882
Number of pages8
JournalNeural Regeneration Research
Volume5
Issue number24
Publication statusPublished - 2010 Dec 1
Externally publishedYes

Fingerprint

Phosphotransferases
Stroke
Brain
Middle Cerebral Artery Infarction
Fibrinolysin
Soybeans
Plasminogen Activators
Plasminogen
Tissue Plasminogen Activator
Enzymes
Therapeutics
Ointments
Bacillus subtilis
Fibrin
Intravenous Infusions
Brain Injuries
Thrombosis
Blood Platelets
Proteins

Keywords

  • Brain damage
  • Cheonggukjang kinase
  • Fibrin clot lysis assay
  • Middle cerebral artery occlusion
  • Platelet rich clot lysis assay
  • Thrombolytic activity

ASJC Scopus subject areas

  • Developmental Neuroscience

Cite this

Jalin, A. M. A., Lee, C. K., Lee, C. Y., Kang, A. R., Park, C. M., Cha, J. H., ... Kang, S. G. (2010). Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model. Neural Regeneration Research, 5(24), 1875-1882.

Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model. / Jalin, Angella M Anthony; Lee, Chae Kwan; Lee, Chae Yeon; Kang, A. Reum; Park, Chung Mu; Cha, Jae Ho; Kim, Jeong Hwan; Lee, Soo Woong; Song, Young Sun; Lee, Jong-Tae; Kang, Sung Goo.

In: Neural Regeneration Research, Vol. 5, No. 24, 01.12.2010, p. 1875-1882.

Research output: Contribution to journalArticle

Jalin, AMA, Lee, CK, Lee, CY, Kang, AR, Park, CM, Cha, JH, Kim, JH, Lee, SW, Song, YS, Lee, J-T & Kang, SG 2010, 'Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model', Neural Regeneration Research, vol. 5, no. 24, pp. 1875-1882.
Jalin, Angella M Anthony ; Lee, Chae Kwan ; Lee, Chae Yeon ; Kang, A. Reum ; Park, Chung Mu ; Cha, Jae Ho ; Kim, Jeong Hwan ; Lee, Soo Woong ; Song, Young Sun ; Lee, Jong-Tae ; Kang, Sung Goo. / Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model. In: Neural Regeneration Research. 2010 ; Vol. 5, No. 24. pp. 1875-1882.
@article{cd66219de83c48998b2c889a9adbd1d7,
title = "Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model",
abstract = "Cheonggukjang is a soybean paste made by fermenting whole cooked soybeans with Bacillus subtilis. Cheonggukjang contains a fibrinolytic enzyme that could provide clinical applications for removing blood clots. In the present study, the term {"}cheonggukjang kinase{"} (CGK) was used to refer to this fibrinolytic enzyme. The thrombolytic effects of CGK were analyzed in a rat model of cerebral embolic stroke produced by middle cerebral artery occlusion (MCAO). Results from fibrin and platelet-rich clot lysis assays demonstrated that thrombolytic activity was greatest in CGKs, which were cultured for 40 hours. In addition, T50, the time needed to decompose 50{\%} of the clot, did not change with plasminogen treatment, indicating that CGK was not a plasminogen activator, but was rather presumed to act as a plasmin-like protein. An intravenous infusion of CGK (1 U plasmin-like activity/100 μg CGK/kg) at 1 hour after MCAO resulted in removal of clots in a rat model of cerebral embolic stroke. CGK-treated groups exhibited a significant dose-dependent reduction in infarct volume. CGK treatment also improved functional recovery, as assessed by neurological deficit scores. Decreased infarct volume and improved functional recovery following CGK treatment was greater compared with recombinant tissue plasminogen activator (10 mg/kg). These results suggested that CGK effectively reduced infarct volume and improved functional recovery following ischemic brain injury. CGK exhibits a number of potential clinical applications in the treatment of cerebral embolic stroke.",
keywords = "Brain damage, Cheonggukjang kinase, Fibrin clot lysis assay, Middle cerebral artery occlusion, Platelet rich clot lysis assay, Thrombolytic activity",
author = "Jalin, {Angella M Anthony} and Lee, {Chae Kwan} and Lee, {Chae Yeon} and Kang, {A. Reum} and Park, {Chung Mu} and Cha, {Jae Ho} and Kim, {Jeong Hwan} and Lee, {Soo Woong} and Song, {Young Sun} and Jong-Tae Lee and Kang, {Sung Goo}",
year = "2010",
month = "12",
day = "1",
language = "English",
volume = "5",
pages = "1875--1882",
journal = "Neural Regeneration Research",
issn = "1673-5374",
publisher = "Editorial Board of Neural Regeneration Research",
number = "24",

}

TY - JOUR

T1 - Thrombolytic activity of cheonggukjang kinase in recovery from brain damage in a rat cerebral embolic stroke model

AU - Jalin, Angella M Anthony

AU - Lee, Chae Kwan

AU - Lee, Chae Yeon

AU - Kang, A. Reum

AU - Park, Chung Mu

AU - Cha, Jae Ho

AU - Kim, Jeong Hwan

AU - Lee, Soo Woong

AU - Song, Young Sun

AU - Lee, Jong-Tae

AU - Kang, Sung Goo

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Cheonggukjang is a soybean paste made by fermenting whole cooked soybeans with Bacillus subtilis. Cheonggukjang contains a fibrinolytic enzyme that could provide clinical applications for removing blood clots. In the present study, the term "cheonggukjang kinase" (CGK) was used to refer to this fibrinolytic enzyme. The thrombolytic effects of CGK were analyzed in a rat model of cerebral embolic stroke produced by middle cerebral artery occlusion (MCAO). Results from fibrin and platelet-rich clot lysis assays demonstrated that thrombolytic activity was greatest in CGKs, which were cultured for 40 hours. In addition, T50, the time needed to decompose 50% of the clot, did not change with plasminogen treatment, indicating that CGK was not a plasminogen activator, but was rather presumed to act as a plasmin-like protein. An intravenous infusion of CGK (1 U plasmin-like activity/100 μg CGK/kg) at 1 hour after MCAO resulted in removal of clots in a rat model of cerebral embolic stroke. CGK-treated groups exhibited a significant dose-dependent reduction in infarct volume. CGK treatment also improved functional recovery, as assessed by neurological deficit scores. Decreased infarct volume and improved functional recovery following CGK treatment was greater compared with recombinant tissue plasminogen activator (10 mg/kg). These results suggested that CGK effectively reduced infarct volume and improved functional recovery following ischemic brain injury. CGK exhibits a number of potential clinical applications in the treatment of cerebral embolic stroke.

AB - Cheonggukjang is a soybean paste made by fermenting whole cooked soybeans with Bacillus subtilis. Cheonggukjang contains a fibrinolytic enzyme that could provide clinical applications for removing blood clots. In the present study, the term "cheonggukjang kinase" (CGK) was used to refer to this fibrinolytic enzyme. The thrombolytic effects of CGK were analyzed in a rat model of cerebral embolic stroke produced by middle cerebral artery occlusion (MCAO). Results from fibrin and platelet-rich clot lysis assays demonstrated that thrombolytic activity was greatest in CGKs, which were cultured for 40 hours. In addition, T50, the time needed to decompose 50% of the clot, did not change with plasminogen treatment, indicating that CGK was not a plasminogen activator, but was rather presumed to act as a plasmin-like protein. An intravenous infusion of CGK (1 U plasmin-like activity/100 μg CGK/kg) at 1 hour after MCAO resulted in removal of clots in a rat model of cerebral embolic stroke. CGK-treated groups exhibited a significant dose-dependent reduction in infarct volume. CGK treatment also improved functional recovery, as assessed by neurological deficit scores. Decreased infarct volume and improved functional recovery following CGK treatment was greater compared with recombinant tissue plasminogen activator (10 mg/kg). These results suggested that CGK effectively reduced infarct volume and improved functional recovery following ischemic brain injury. CGK exhibits a number of potential clinical applications in the treatment of cerebral embolic stroke.

KW - Brain damage

KW - Cheonggukjang kinase

KW - Fibrin clot lysis assay

KW - Middle cerebral artery occlusion

KW - Platelet rich clot lysis assay

KW - Thrombolytic activity

UR - http://www.scopus.com/inward/record.url?scp=78751634114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751634114&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:78751634114

VL - 5

SP - 1875

EP - 1882

JO - Neural Regeneration Research

JF - Neural Regeneration Research

SN - 1673-5374

IS - 24

ER -